288 related articles for article (PubMed ID: 35741019)
21. Low bone mineral density is a common feature of Zellweger spectrum disorders.
Rush ET; Goodwin JL; Braverman NE; Rizzo WB
Mol Genet Metab; 2016 Jan; 117(1):33-7. PubMed ID: 26643206
[TBL] [Abstract][Full Text] [Related]
22. Zellweger Syndrome: A Case Report.
Yogi P; Bahik C; Yadav R; Bhattarai P; Pandey R; Manandar SR
JNMA J Nepal Med Assoc; 2024 Feb; 62(270):155-157. PubMed ID: 38409970
[TBL] [Abstract][Full Text] [Related]
23. It's Never Too Late for a Diagnosis.
Coelho M; Durães J; Freixo J; Tomás J; Macário C
Endocr Metab Immune Disord Drug Targets; 2023 Oct; ():. PubMed ID: 37859411
[TBL] [Abstract][Full Text] [Related]
24. High Dose Versus Low Dose Syngeneic Hepatocyte Transplantation in
Demaret T; Evraerts J; Ravau J; Roumain M; Muccioli GG; Najimi M; Sokal EM
Cells; 2020 Dec; 10(1):. PubMed ID: 33396635
[TBL] [Abstract][Full Text] [Related]
25. Novel PEX1 mutations in fibroblasts from children with Zellweger spectrum disorders exhibit temperature sensitive characteristics.
Liang JS; Hung KL; Lin LJ; Ong WP; Keng WT; Lu JF
Epilepsy Behav; 2023 Aug; 145():109266. PubMed ID: 37385119
[TBL] [Abstract][Full Text] [Related]
26. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
[TBL] [Abstract][Full Text] [Related]
27. Histologic and ultrastructural features in early and advanced phases of Zellweger spectrum disorder (infantile Refsum disease).
Warren M; Mierau G; Wartchow EP; Shimada H; Yano S
Ultrastruct Pathol; 2018; 42(3):220-227. PubMed ID: 29482424
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic Hematopoietic Stem Cell Transplantation for PEX1-Related Zellweger Spectrum Disorder: A Case Report and Literature Review.
Chen K; Zhang N; Shao JB; Li H; Li J; Xi JM; Xu WH; Jiang H
Front Pediatr; 2021; 9():672187. PubMed ID: 34513757
[TBL] [Abstract][Full Text] [Related]
29. Genotype-phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders.
Borgia P; Baldassari S; Pedemonte N; Alkhunaizi E; D'Onofrio G; Tortora D; Calì E; Scudieri P; Balagura G; Musante I; Diana MC; Pedemonte M; Vari MS; Iacomino M; Riva A; Chimenz R; Mangano GD; Mohammadi MH; Toosi MB; Ashrafzadeh F; Imannezhad S; Karimiani EG; Accogli A; Schiaffino MC; Maghnie M; Soler MA; Echiverri K; Abrams CK; Striano P; Fortuna S; Maroofian R; Houlden H; Zara F; Fiorillo C; Salpietro V
Orphanet J Rare Dis; 2022 Jul; 17(1):286. PubMed ID: 35854306
[TBL] [Abstract][Full Text] [Related]
30. Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders.
Stradomska TJ; Syczewska M; Jamroz E; Pleskaczyńska A; Kruczek P; Ciara E; Tylki-Szymanska A
PLoS One; 2020; 15(9):e0238796. PubMed ID: 32946460
[TBL] [Abstract][Full Text] [Related]
31. Severe Zellweger spectrum disorder due to a novel missense variant in the PEX13 gene: A case report and the literature review.
Su L; Peng MZ; Chen XD; Wu S; Liu L
Mol Genet Genomic Med; 2024 Jan; 12(1):e2315. PubMed ID: 37962062
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case report.
Blomqvist M; Ahlberg K; Lindgren J; Ferdinandusse S; Asin-Cayuela J
J Med Case Rep; 2017 Aug; 11(1):218. PubMed ID: 28784167
[TBL] [Abstract][Full Text] [Related]
33. Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools.
Vasiljevic E; Ye Z; Pavelec DM; Darst BF; Engelman CD; Baker MW
Genet Med; 2019 Sep; 21(9):1969-1976. PubMed ID: 30846882
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders.
Jaspers YRJ; Ferdinandusse S; Dijkstra IME; Barendsen RW; van Lenthe H; Kulik W; Engelen M; Goorden SMI; Vaz FM; Kemp S
Front Cell Dev Biol; 2020; 8():690. PubMed ID: 32903870
[TBL] [Abstract][Full Text] [Related]
35. Zellweger spectrum disorders: clinical overview and management approach.
Klouwer FC; Berendse K; Ferdinandusse S; Wanders RJ; Engelen M; Poll-The BT
Orphanet J Rare Dis; 2015 Dec; 10():151. PubMed ID: 26627182
[TBL] [Abstract][Full Text] [Related]
36. Accurate and live peroxisome biogenesis evaluation achieved by lentiviral expression of a green fluorescent protein fused to a peroxisome targeting signal 1.
Demaret T; Courtoy GE; Ravau J; Van Der Smissen P; Najimi M; Sokal EM
Histochem Cell Biol; 2020 May; 153(5):295-306. PubMed ID: 32124009
[TBL] [Abstract][Full Text] [Related]
37. Genome sequencing identifies a rare case of moderate Zellweger spectrum disorder caused by a
Lee W; Costain G; Blaser S; Walker S; Marshall CR; Gonorazky H; Inbar-Feigenberg M
Mol Genet Metab Rep; 2020 Dec; 25():100664. PubMed ID: 33101983
[TBL] [Abstract][Full Text] [Related]
38. Child neurology: Zellweger syndrome.
Lee PR; Raymond GV
Neurology; 2013 May; 80(20):e207-10. PubMed ID: 23671347
[TBL] [Abstract][Full Text] [Related]
39. Clinical, neuroradiological, and molecular characterization of patients with atypical Zellweger spectrum disorder caused by PEX16 mutations: a case series.
Cheung A; Argyriou C; Yergeau C; D'Souza Y; Riou É; Lévesque S; Raymond G; Daba M; Rtskhiladze I; Tkemaladze T; Adang L; La Piana R; Bernard G; Braverman N
Neurogenetics; 2022 Apr; 23(2):115-127. PubMed ID: 35106698
[TBL] [Abstract][Full Text] [Related]
40. A novel mutation in the
Semenova NA; Kurkina MV; Marakhonov AV; Dadali EL; Taran NN; Strokova TV
Mol Genet Metab Rep; 2021 Jun; 27():100754. PubMed ID: 33912394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
